Jun 10, 2020 / 08:40PM GMT
Terence C. Flynn - Goldman Sachs Group, Inc., Research Division - MD
Great. Good afternoon, everybody. Thank you for joining us. I'm Terence Flynn, the biopharma analyst at Goldman Sachs. Very pleased to be hosting CytomX this afternoon as part of our virtual conference. Joining us from the company is Sean McCarthy, who's President, CEO and Chairman.
Sean, thank you very much for joining us. Really appreciate your time today.
Sean A. McCarthy - CytomX Therapeutics, Inc. - Chairman, CEO & President
Great. Thanks, Terence. Absolute pleasure to be here.
Questions and Answers:
Terence C. Flynn - Goldman Sachs Group, Inc., Research Division - MDMaybe just to start, I thought you could set the stage and give a little bit of an overview of the company and the strategy for those on the webcast that maybe aren't as familiar with what you guys have been working on over the last several years.
Sean A. McCarthy - CytomX Therapeutics, Inc. - Chairman, CEO & President
Trustpilot
